Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metvix NDL-PDT vs c-PDT in Actinic Keratosis
NCT01821391Phase 3Completed
- Sponsor
- Galderma
- Start
- Jul 2013
- Primary completion
- Jan 2014
- Modality
- Light/Condition-Responsive Prodrugs
- Countries
- 5
01
Overview
A Phase 3 trial of methyl aminolevulinate in actinic keratosis (AK), sponsored by Galderma. Started Jul 2013; status: completed.
02
Drugs
methyl aminolevulinate
03
Conditions
actinic keratosis (AK)
Beyond the preview
Go deeper on NCT01821391.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01821391.